Feasibility of Blood Glucose Management Using Intra-Arterial Glucose Monitoring in Combination with an Automated Insulin Titration Algorithm in Critically Ill Patients

Julia K Mader, Melanie Motschnig, Verena Theiler-Schwetz, Karin Eibel-Reisz, Alexander C Reisinger, Bettina Lackner, Thomas Augustin, Philipp Eller, Claudia Mirth

Publikation: Beitrag in Fachzeitschrift (peer-reviewed)Artikel in Fachzeitschrift

2 Zitate (Scopus)

Abstract

Background: This two-center pilot study combined for the first time an intra-arterial glucose sensor with a decision support system for insulin dosing (SGCplus system) in critically ill patients with hyperglycemia. Methods: Twenty-two patients who were equipped with an arterial line and required iv insulin therapy were managed by the SGCplus system during their medical treatment at the intensive care unit. Results: Time to target was 111 ± 195 min (80-150 mg/dL) and 135 ± 267 min (100-160 mg/dL) in the lower and higher glucose target group. Mean blood glucose (BG) was 142 ± 32 mg/dL with seven BG values <70 mg/dL. Mean daily insulin dose was 62 ± 38 U and mean daily carbohydrate intake 148 ± 50 g/day (enteral nutrition) and 102 ± 58 g/day (parenteral nutrition). Acceptance of SGCplus suggestions was high (93%). Conclusions: The SGCplus system can be safely applied in critically ill patients with hyperglycemia and enables good glycemic control.

OriginalspracheEnglisch
Seiten (von - bis)566-574
Seitenumfang8
FachzeitschriftDiabetes Technology and Therapeutics
Jahrgang21
Ausgabenummer10
DOIs
PublikationsstatusVeröffentlicht - Okt. 2019

ASJC Scopus Sachgebiete

  • Medizinische Labortechnik
  • Endokrinologie
  • Endokrinologie, Diabetes und Stoffwechsel

Fingerprint

Untersuchen Sie die Forschungsthemen von „Feasibility of Blood Glucose Management Using Intra-Arterial Glucose Monitoring in Combination with an Automated Insulin Titration Algorithm in Critically Ill Patients“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren